Complement C7 (C7), a Potential Tumor Suppressor, Is an Immune-Related Prognostic Biomarker in Prostate Cancer (PC)

Objectives: Prostate cancer (PC) is the second most frequent tumor in men, which has a high recurrence rate and poor prognosis. Therefore, this study aimed to identify novel prognostic biomarkers and therapeutic targets for immunotherapy and small molecule drugs for PC treatment. Materials and Metho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Chen, Zhao, Yan, Xin, Du, Guo-Wei, Tuoheti, Kurerban, Bai, Xiao-Jie, Wu, Hua-Hui, Zhang, Ren-Jie, Xiao, Guan-Fa, Liu, Tong-Zu
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477933/
https://ncbi.nlm.nih.gov/pubmed/32984006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01532
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars